HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Salar Selected Research

Myelodysplastic Syndromes (Myelodysplastic Syndrome)

1/2022Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.
4/2017Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Salar Research Topics

Disease

16Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 03/2009
15Neoplasms (Cancer)
01/2021 - 10/2005
13Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2022 - 12/2008
13Lymphoma (Lymphomas)
04/2020 - 10/2005
9Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
12/2021 - 10/2005
6Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 10/2002
5B-Cell Lymphoma (Lymphoma, B Cell)
04/2020 - 12/2008
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2022 - 10/2013
3Pulmonary Embolism
04/2021 - 11/2020
3COVID-19
04/2021 - 11/2020
3Hodgkin Disease (Hodgkin's Disease)
06/2015 - 09/2010
3Central Nervous System Diseases (CNS Diseases)
07/2014 - 03/2009
2Chromosome Aberrations (Chromosome Abnormalities)
01/2022 - 09/2010
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 04/2017
2Pathologic Complete Response
04/2021 - 10/2013
2Agranulocytosis (Granulocytopenia)
01/2021 - 03/2017
2Pneumonia (Pneumonitis)
11/2020 - 11/2020
2Multiple Myeloma
05/2016 - 06/2012
2Febrile Neutropenia
10/2015 - 05/2012
1Neutropenia
01/2021
1Primary Myelofibrosis (Myelosclerosis)
01/2021
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2021
1T-Cell Lymphoma (Lymphoma, T Cell)
04/2020
1Disease Progression
01/2020
1Cardiotoxicity
06/2019
1Second Primary Neoplasms (Neoplasms, Second)
10/2017
1Pancytopenia
03/2017
1Aplastic Anemia (Anemia, Hypoplastic)
03/2017
1Chronic Hepatitis C
03/2017
1Xanthomatosis (Xanthoma)
01/2017
1Gastritis
01/2017
1Angioedema
04/2016
1Burkitt Lymphoma (Burkitt's Lymphoma)
07/2014
1Lymphocytosis
02/2014
1Arachnoiditis
04/2013
1Paronychia
04/2013
1Lymphadenopathy
10/2012
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2012

Drug/Important Bio-Agent (IBA)

31Rituximab (Mabthera)FDA Link
01/2022 - 10/2005
9Bendamustine HydrochlorideFDA Link
01/2021 - 03/2009
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2017 - 08/2009
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 09/2010
4Biological ProductsIBA
04/2020 - 03/2009
4fludarabineIBA
04/2017 - 08/2009
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2015 - 01/2006
4Cytarabine (Cytosar-U)FDA LinkGeneric
10/2013 - 10/2002
3MicroRNAs (MicroRNA)IBA
02/2022 - 01/2017
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2020
3fibrin fragment D (D-dimer)IBA
04/2021 - 11/2020
3Biomarkers (Surrogate Marker)IBA
12/2017 - 06/2011
3Lenalidomide (CC 5013)FDA Link
04/2016 - 04/2013
3Vincristine (Oncovin)FDA LinkGeneric
01/2016 - 05/2011
2Cell-Free Nucleic AcidsIBA
01/2022 - 01/2021
2Mitoxantrone (Novantrone)FDA LinkGeneric
11/2019 - 04/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2019 - 10/2002
2AnthracyclinesIBA
06/2019 - 06/2015
2pro-brain natriuretic peptide (1-76)IBA
06/2019 - 06/2011
2Proteins (Proteins, Gene)FDA Link
07/2017 - 01/2016
2Alkylating AgentsIBA
05/2016 - 06/2012
2Prednisolone (Predate)FDA LinkGeneric
05/2012 - 05/2011
2Hemoglobins (Hemoglobin)IBA
05/2011 - 09/2010
2Etoposide (VP 16)FDA LinkGeneric
12/2008 - 10/2002
2MethylprednisoloneFDA LinkGeneric
12/2008 - 10/2002
1ibrutinibIBA
09/2022
1ibritumomab tiuxetan (Zevalin)FDA Link
01/2022
14- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA
04/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2021
1Anaplastic Lymphoma KinaseIBA
04/2020
13- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA
01/2020
1Natriuretic PeptidesIBA
06/2019
1Dihydrotachysterol (AT 10)IBA
10/2017
1InterferonsIBA
03/2017
1telaprevirIBA
03/2017
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
03/2017
1SofosbuvirIBA
03/2017
1Protease Inhibitors (Protease Inhibitor)IBA
03/2017
1SimeprevirIBA
03/2017
1Ribavirin (Virazole)FDA LinkGeneric
03/2017
1Prednisone (Sone)FDA LinkGeneric
01/2016
1VorinostatFDA Link
01/2016
1Cyclin D1IBA
02/2014
1CyclinsIBA
02/2014
1pegfilgrastim (Neulasta)FDA Link
10/2013
1Methotrexate (Mexate)FDA LinkGeneric
10/2013
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2012
1purineIBA
06/2012
1Bleomycin (Blenoxane)FDA LinkGeneric
05/2012
1Dacarbazine (DIC)FDA LinkGeneric
05/2012
1Vinblastine (Vinblastine Sulfate)FDA Link
05/2012
1Anti-Bacterial Agents (Antibiotics)IBA
01/2012

Therapy/Procedure

17Therapeutics
12/2019 - 11/2007
13Drug Therapy (Chemotherapy)
01/2021 - 10/2005
8Stem Cell Transplantation
12/2019 - 10/2002
2VAP-cyclo protocol
02/2022 - 03/2011
2Secondary Prevention
12/2019 - 12/2018
2Salvage Therapy
11/2019 - 12/2008
1Precision Medicine
12/2021
1Immunotherapy
12/2019
1Intravenous Administration
06/2014
1Aftercare (After-Treatment)
01/2012